Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Not on Peppol Peppol
Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.
Financials
Financial year 2025
Dr Charlotte VAN ENDE - Néphrologie et médecine interne générale from Namur, company number BE0651896616, closed financial year 2025 with a result of € -13,314 after tax. For that financial year Dr Charlotte VAN ENDE - Néphrologie et médecine interne générale recorded a gross margin of € -5,132 and equity of € 230,441. Compared with financial year 2024, the result moved from € 19,087 to € -13,314. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on March 16, 2026.
€ 230,441
▼ 5% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -13,314
▼ still € 19,087 profit in 2024
Profit after tax over the fiscal year.
€ 7,089
▼ 68% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € 211,841.
People and assets in 2025
≈ 1
No payroll staff. One director, so that person most likely runs the business.
€ 2,205
▼ 37% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 511
Supplier invoices still open on the last day of the fiscal year.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 28,427 | € -695 | € 717 | € -5,132 | ▼ € 5,850 |
| Profit after taxes | € 1,139 | € -8,596 | € 19,087 | € -13,314 | ▼ € 32,401 |
| Equity | € 233,266 | € 224,669 | € 243,756 | € 230,441 | ▼ 5% |
| Total debts | € 74,936 | € 20,822 | € 9,038 | € 511 | ▼ 94% |
| Cash | € 54,578 | € 9,990 | € 21,884 | € 7,089 | ▼ 68% |
| Land & buildings | € 31,574 | € 29,740 | € 29,282 | € 26,072 | ▼ 11% |
| Retained profit | € 214,666 | € 206,069 | € 225,156 | € 211,841 | ▼ 6% |
| Bank debt | € 50,519 | € 20,822 | € 6,666 | € 0 | ▼ 100% |
| Balance sheet total | € 308,201 | € 245,491 | € 252,794 | € 230,953 | ▼ 9% |
Key figures of Dr Charlotte VAN ENDE - Néphrologie et médecine interne générale, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 January 2027.
What happened to Dr Charlotte VAN ENDE - Néphrologie et médecine interne générale?
What happened at Dr Charlotte VAN ENDE - Néphrologie et médecine interne générale in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 13,314 (▼ € 32,401 vs 2024). filed late Source: NBB ↗
- New establishment in Namur. KBO
- PIERRARD VAN ENDE INVEST SPRL became a director. NBB
- New establishment in Namur. KBO
- Start of the company according to the CBE. KBO
- CHARLOTTE VAN ENDE became a director. NBB
In short
From € 1,139 profit in 2022 to € 13,314 loss in 2025.
Paid € 4,293 in corporate taxes since 2022.
Best year ever: 2024, with € 19,087 profit.
A new publication or filing at Dr Charlotte VAN ENDE - Néphrologie et médecine interne générale? We notify you, reason included.
Follow Dr Charlotte VAN ENDE - Néphrologie et médecine interne généraleDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind Dr Charlotte VAN ENDE - Néphrologie et médecine interne générale are PIERRARD VAN ENDE INVEST SPRL and CHARLOTTE VAN ENDE.
Directors
According to the 2025 annual accounts
Director · represented by DAMIEN PIERRARD
since 2017
CHARLOTTE VAN ENDE
Director
since 2015
Establishments
Establishment units
Physical locations of this company
Rue de Bauw(ML) 25
5020 Namur
Place Louise Godin 15
5000 Namur
Active since 13 April 2016
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0651.896.616
- VAT number
- BE 0651.896.616
- Registered office
- Rue de Bauw(ML) 25, 5020 Namur
- Names & denominations
- Dr Charlotte VAN ENDE - Néphrologie et médecine interne générale
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 13 April 2016
- Peppol
- Not registered
- Activities · NACE
Activiteiten van medisch specialisten